Sensus Healthcare, Inc. (NASDAQ:SRTS) Shares Sold by Mindset Wealth Management LLC

Mindset Wealth Management LLC lessened its holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS) by 7.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,100 shares of the company’s stock after selling 3,000 shares during the quarter. Mindset Wealth Management LLC owned approximately 0.21% of Sensus Healthcare worth $243,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Truvestments Capital LLC acquired a new position in shares of Sensus Healthcare in the 3rd quarter valued at about $32,000. Geode Capital Management LLC lifted its holdings in Sensus Healthcare by 8.5% in the third quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock worth $849,000 after acquiring an additional 11,525 shares during the last quarter. XTX Topco Ltd boosted its stake in Sensus Healthcare by 76.0% in the third quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock valued at $183,000 after acquiring an additional 13,619 shares during the period. IFP Advisors Inc bought a new position in shares of Sensus Healthcare during the fourth quarter valued at approximately $95,000. Finally, Ritholtz Wealth Management raised its position in shares of Sensus Healthcare by 65.3% during the 4th quarter. Ritholtz Wealth Management now owns 51,261 shares of the company’s stock worth $355,000 after purchasing an additional 20,256 shares during the period. Institutional investors own 25.30% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. HC Wainwright boosted their price objective on Sensus Healthcare from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Monday, February 10th. Lake Street Capital reduced their price target on shares of Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating for the company in a report on Tuesday, March 11th.

Sensus Healthcare Price Performance

Shares of SRTS stock opened at $4.74 on Friday. Sensus Healthcare, Inc. has a 12-month low of $3.09 and a 12-month high of $9.33. The firm has a market capitalization of $78.19 million, a price-to-earnings ratio of 11.85 and a beta of 1.28. The business has a 50 day simple moving average of $5.85 and a 200 day simple moving average of $6.60.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a net margin of 15.90% and a return on equity of 12.60%. On average, equities analysts anticipate that Sensus Healthcare, Inc. will post 0.32 EPS for the current fiscal year.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.